About
Evotec Se (XETRA:EVT) — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 8 2026
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Jan 2 2026
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Dec 8 2025
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
Dec 4 2025
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Nov 12 2025
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Financials
Revenue
€756.33 M
Market Cap
€800.39 M
EPS
-0.90
Translate